SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.

Candida krusei is increasingly recognized as an opportunistic pathogen in immunocompromised patients and is inherently resistant to fluconazole. We tested the in vivo efficacy of SCH 51048, an investigational antifungal triazole, in experimental hematogenous murine infection caused by two C. krusei...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Karyotakis, N C, Dignani, M C, Anaissie, E J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.775
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!